Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Microbot Medical Inc.

< Previous 1 2 Next >
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Shares Status Following Recent Geopolitical Events
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS